Immunology

The long history of insulin discovery and its development for treating diabetes is marked with determination and serendipity, collaboration and controversy.

LIVE November 30th, 2021 at 11:00 AM ET
Discover how scientists use flow cytometry technology to improve regenerative medicine

LIVE November 29th, 2021 at 11:00 AM ET
Investigating the pathophysiology and spread of human viruses

A young cancer researcher made a big splash when she discovered that inhibiting DNA damage response proteins sensitizes treatment-resistant lung cancer cells to immunotherapy.

Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.

LIVE October 13th, 2021 at 10:30 AM ET
Experts will discuss advances that bring CAR therapy for solid tumors one step closer to reality.

A new delivery system initially developed to treat asthma sends corticosteroids deep into the lungs where COVID-19 infects cells, potentially slowing viral replication.

LIVE October 12th, 2021 at 11:30 AM ET

Bill Thelin will discuss how intestine-on-a chip technology reliably models gastrointestinal disease and assists researchers in screening for safe, effective therapeutic candidates.

New technology turns red blood cells into artificial antigen-presenting cells. These cells activate T cells to attack HPV-driven cancers.

Unlike other cells in the body that mount a strong immune response against microbial invaders, skin cells use an epigenetic mechanism to ignore most of the microbes they see. These findings reveal a potential new drug target for inflammatory skin diseases.